Exelixis, Inc. (NASDAQ:EXEL) Q3 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to Exelixis Third Quarter 2024 Financial Results Conference Call. My name is Towanda, and I will be your operator for today.
Exelixis Inc. (EXEL)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Farallon Capital Thomas Steyer | 25,410,500 | $659,402,475 | -7% | 3.22% |
| 2. | Renaissance Technologies Jim Simons | 15,359,916 | $398,589,820 | +2% | 0.59% |
| 3. | AQR Capital Management Cliff Asness | 3,156,148 | $81,902,041 | -4% | 0.11% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 1,702,590 | $44,182,211 | +7% | 0.1% |
| 5. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,545,913 | $40,116,442 | +30% | 0.03% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.76 | 225,000 | Director | 1,525,730 | 2024-05-30 | Filing | |
| $20.32 | 200,000 | Director | 1,300,730 | 2024-05-28 | Filing | |
| $20.70 | 190,000 | Director | 1,100,730 | 2024-02-21 | Filing | |
| $21.61 | 120,409 | Director | 910,730 | 2023-11-27 | Filing | |
| $4.95 | 20,000 | Director | 568,273 | 2016-05-11 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.67 | 60,000 | Officer | 486,059 | 2024-11-29 | Filing | |
| $35.27 | 10,000 | Officer | 278,665 | 2024-11-22 | Filing | |
| $34.41 | 19,381 | Officer | 288,665 | 2024-11-18 | Filing | |
| $34.31 | 22,207 | Officer | 308,046 | 2024-11-18 | Filing | |
| $35.00 | 96,986 | Officer | 498,945 | 2024-11-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 36,014,432 | $863,986,223 | 0.02% | |
| 2. | 31,671,090 | $759,789,450 | 0.01% | |
| 3. | 13,032,818 | $312,657,304 | 0.01% | |
| 4. | 7,741,589 | $185,720,735 | 0.01% | |
| 5. | 5,145,318 | $123,455,190 | 0.01% |
News See All
10 Largest Biotech Hedge Funds and Their Top Stock Picks
The ability to successfully make money through investment requires deep thinking and analysis.
Top 10 Holdings of Caligan Partners
Founded in 2017, Caligan Partners is one of the most significant specialty hedge funds.
Exelixis, Inc. (NASDAQ:EXEL) Q2 2024 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Second Quarter 2024 Financial Results Conference Call. My name is Tawanda and I'll be your operator for today.
Exelixis, Inc. (NASDAQ:EXEL) Q1 2024 Earnings Call Transcript
Exelixis, Inc. misses on earnings expectations. Reported EPS is $0.17 EPS, expectations were $0.28.
Insiders Are Dumping These 10 Healthcare Stocks
In this article, we will take a detailed look at Insiders Are Dumping These 10 Healthcare Stocks. For a quick overview of such stocks, read our article Insiders Are Dumping These 5 Healthcare Stocks...
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
10 Biotech Stocks with Huge Potential
In this article, we will take a look at the 10 biotech stocks with huge potential.
10 Mid-Cap Stocks with Insider Purchases
Investors are yet again in a wait-and-see mode ahead of key jobs and inflation numbers, but the overall sentiment in the market is positive, helped by the Fed Chair Jerome Powell’s latest statement ...
Exelixis, Inc. (NASDAQ:EXEL) Q4 2023 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Exelixis Fourth Quarter and Fiscal Year 2023 Financial Results Conference Call. My name is Tawanda, and I will be your operator for today.
Billionaire Hedge Funds
